Pulsenmore Launches At-Home Fertility Monitoring Service with Clalit Health Services, Securing $4.5M Deal
PLSM is trading near its 52-week low of $5.81 (9.5% above the low).
Summary
Pulsenmore Ltd. announced a strategic commercial agreement with Clalit Health Services, Israel's largest HMO, to launch its Pulsenmore FC at-home follicular monitoring service, potentially valued at $4.5 million over five years.
Key Events · M&A and Partnerships · PLSM
-
Feasibility Trial Success Confirmed
Clalit Health Services confirmed that the feasibility trial for Pulsenmore FC met the study protocol criteria, paving the way for commercialization.
-
New Commercial Agreement Signed
Pulsenmore and Clalit entered into an 18-month pilot period, followed by a five-year commercial term for the Pulsenmore FC system, an increase from the previous four-year term.
-
Significant Revenue Potential
The agreement is potentially valued at approximately $4.5 million over five years following the pilot, with a minimum annual purchase commitment of 2,000 Pulsenmore FC units.
-
Innovative At-Home Fertility Monitoring
The service will be deployed via Beilinson NEXT, Rabin Medical Center's virtual hospital platform, enabling patients to perform follicular monitoring scans from home with clinical oversight.
Analysis · PLSM · Industrial Applications And Services
This filing announces a significant commercial agreement for Pulsenmore's at-home follicular monitoring system (Pulsenmore FC) with Clalit Health Services, Israel's largest HMO. The agreement, potentially valued at $4.5 million over five years, follows the successful completion of a feasibility trial, which was a condition of the initial 2021 agreement. This represents a substantial revenue stream for Pulsenmore relative to its market capitalization and validates its technology for a critical application in fertility care. The partnership expands Pulsenmore's existing relationship with Clalit and establishes an innovative care model through a virtual hospital platform, enhancing patient access and convenience for IVF and fertility preservation.
At the time of this filing, PLSM was trading at $6.36 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $38.5M. The 52-week trading range was $5.81 to $10.28. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.